Epoch 29: Unlocking Biopharma Gains by Mimicking Top Hedge Funds
Strategies for using 13F to Mimic HF Trading
Hello Avatar! Welcome back for another week of biotech analysis. Today is Sunday, which means this is our Building Biotech newsletter that is focused on discussing biopharma strategy topics. We are going to cover a topic many of you are interested in - mimicking hedge fund investment strategies within your own portfolios. Each quarter hedge funds are required to disclose their holdings via the 13F filing. Savvy investors can track this information to inform their own investment portfolios and strategies. Today we will show you how and comment on the effectiveness of such approaches.
If you're not subbed yet click the link below. Every Thursday we are out with our FREE public/private biotech market update. Sundays are the days we focus on forward looking strategy. Monday’s are for public equity research. Tomorrow we will focus on ALX Oncology who will share data from the Evorpacept ASPEN-06 Phase 2 study in Gastric Cancer. Options pricing suggest ~100% volatility!
Please help spread the work by subscribing and hitting the share button if you are enjoying our bi-weekly newsletters!
Enough shilling for the day, lots to cover this week, let's get started!
The Power of Investing in Smid-Cap Biopharma Through Hedge Fund Favorites
Every quarter, SEC-registered hedge funds are mandated to disclose their holdings through a form known as the 13F. This data release is eagerly anticipated, as it allows for the calculation of quarterly hedge fund returns. Although the calculation isn't flawless (the reasons for this will be discussed later), it serves as a valuable proxy into the often opaque world of hedge funds. Astute investors can leverage this information to emulate hedge fund portfolios, aiming to capitalize on the strategies and operations of these sophisticated investment firms.
The 13F filings provide insights into the equity positions of hedge funds, revealing their investment strategies and stock preferences. By analyzing these filings, investors can identify trends and shifts in market sentiment among some of the most influential market players. This information can be particularly useful for constructing a diversified portfolio that mirrors the asset allocations of top-performing hedge funds.
After reading today’s analysis you will have the tools to create and manage your own hedge fund mimic portfolio.
The Analysis
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.